123 related articles for article (PubMed ID: 28891831)
1. Mucosal Cytokine Profiles After Induction Therapy With Granulocyte/Monocyte Apheresis in New-onset Inflammatory Colitis.
Rolandsdotter H; Jönsson-Videsäter K; L Fagerberg U; Eberhardson M; Finkel Y
J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):e103-e107. PubMed ID: 28891831
[TBL] [Abstract][Full Text] [Related]
2. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New-Onset Inflammatory Bowel Colitis.
Rolandsdotter H; Eberhardson M; Fagerberg UL; Finkel Y
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):84-89. PubMed ID: 28604509
[TBL] [Abstract][Full Text] [Related]
4. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.
Tanaka T; Sugiyama S; Goishi H; Kajihara T; Akagi M; Miura T
BMC Gastroenterol; 2013 Aug; 13():130. PubMed ID: 23961883
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
6. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
Yamamoto T; Umegae S; Matsumoto K
J Crohns Colitis; 2012 Aug; 6(7):750-5. PubMed ID: 22398094
[TBL] [Abstract][Full Text] [Related]
8. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings.
Yamamoto T; Saniabadi AR; Umegae S; Matsumoto K
Inflamm Bowel Dis; 2006 Aug; 12(8):719-26. PubMed ID: 16917227
[TBL] [Abstract][Full Text] [Related]
9. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
[TBL] [Abstract][Full Text] [Related]
10. Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis.
Olsen T; Rismo R; Gundersen MD; Paulssen EJ; Johnsen K; Kvamme JM; Goll R; Florholmen J
Cytokine; 2016 Mar; 79():90-5. PubMed ID: 26775117
[TBL] [Abstract][Full Text] [Related]
11. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
[TBL] [Abstract][Full Text] [Related]
12. The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis.
Toya Y; Chiba T; Mizutani T; Sato K; Kasugai S; Matsuda N; Orikasa S; Shibata S; Abiko Y; Akasaka R; Yokoyama N; Oana S; Hirota S; Endo M; Suzuki K
Cytokine; 2013 Apr; 62(1):146-50. PubMed ID: 23465691
[TBL] [Abstract][Full Text] [Related]
13. A multi center study of granulocyte and monocyte adsorption apheresis therapy for ulcerative colitis-clinical efficacy and production of interleukin-1 receptor antagonist.
Takeda H; Suzuki Y; Takeda Y; Nishise S; Fukui T; Fujishima S; Orii T; Otake S; Sato T; Suzuki K; Nakamuara Y; Kawata S
J Clin Apher; 2008; 23(3):105-10. PubMed ID: 18449931
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA and granulocyte-monocyte adsorption apheresis combotherapy after inadequate response to anti-TNF agents in ulcerative colitis.
Sáez-González E; Moret-Tatay I; Bastida G; Aguas M; Iborra M; Nos P; Beltrán B
J Clin Apher; 2024 Feb; 39(1):e22101. PubMed ID: 38054256
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.
Ruuska T; Wewer V; Lindgren F; Malmborg P; Lindquist M; Marthinsen L; Browaldh L; Casswall T; Kalliomäki M; Grönlund J
Inflamm Bowel Dis; 2009 Jul; 15(7):1049-54. PubMed ID: 19137602
[TBL] [Abstract][Full Text] [Related]
16. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
[TBL] [Abstract][Full Text] [Related]
17. Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy.
Sagawa T; Kakizaki S; Tomizawa T; Nakayama T; Tanaka H; Tojima H; Sato K; Kusano M; Okamura S; Yamada M
Colorectal Dis; 2016 Jul; 18(7):696-702. PubMed ID: 26748553
[TBL] [Abstract][Full Text] [Related]
18. Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancy.
D'Ovidio V; Meo D; Gozer M; Bazuro ME; Vernia P
J Clin Apher; 2015 Feb; 30(1):55-7. PubMed ID: 25181523
[TBL] [Abstract][Full Text] [Related]
19. Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease.
Edfors K; Ståhlberg D; Söderman C
Ther Apher Dial; 2016 Feb; 20(1):79-85. PubMed ID: 26841133
[TBL] [Abstract][Full Text] [Related]
20.
Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
